Advertisement

Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group

Published:October 04, 2020DOI:https://doi.org/10.1016/j.ejca.2020.08.030

      Highlights

      • Sentinel node mapping allows identification of extrauterine (i.e. lymphatic) disease.
      • Cervical (CI) and hysteroscopic (HI) injections are to perform sentinel node mapping.
      • CI and HI injections provide a similar detection rate in the para-aortic area.
      • In comparison with HI injection, CI injection correlates with a higher pelvic sentinel node detection rate.

      Abstract

      Aim

      During the last years, the role of sentinel lymph node mapping (SLNM) for endometrial cancer (EC) surgical treatment has increased in popularity. However, several controversies remain about different technical steps of SLNM. Thus, a randomised control trial was designed to compare cervical (CI) and hysteroscopic (HI) indocyanine green (ICG) injection for SLNM of newly diagnosed EC undergoing surgical staging. The primary end-point of the study was to compare these two techniques in terms of para-aortic detection rate.

      Methods

      Patients with apparent stage I or II histologically confirmed EC undergoing surgery were included in the study. This randomised trial distinguished patients in two study groups according to two different techniques of ICG SLNM: CI versus HI injection. Patients who met the inclusion criteria were randomly assigned to CI or HI injection in a 1:1 ratio. The central randomisation system allocated patient randomisation numbers sequentially in the order in which the patients were enrolled. This randomised trial was not blinded for either patients or the surgeons.

      Results

      From March 2017 until April 2019, a total of 165 patients were randomised in this study: 85 (51.5%) in the CI group and 80 (48.5%) in the HI group. After randomisation, 14 (8.5%) patients were excluded from the study. Finally, 151 patients were included in the analysis: 82 (54.3%) in the CI group and 69 (45.7%) in the HI group. Hysteroscopy injection shows an ability to detect Sentinel nodes (SNLs) in the para-aortic area of about 10% greater compared with CI injection, although this difference did not reach statistical significance. The HI technique was superior in detecting isolated para-aortic SLNs (5.8% Versus 0%). The CI injection was correlated with higher SLN detection rates at the pelvic level compared with HI injection. Pelvic and overall detection was higher in the CI group.

      Conclusions

      The present study supports the adoption of CI instead of HI injection because the former allows better identification of sentinel nodes (especially in the pelvic area). Detection of SLN in the para-aortic area was slightly higher in patients receiving a HI injection, but the difference with the CI route was not statistically significant.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bray F.
        • Ferlay J.
        • Soerjomataram I.
        • Siegel R.L.
        • Torre L.A.
        • Jemal A.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424https://doi.org/10.3322/caac.21492
        • Siegel R.L.
        • Miller K.D.
        • Goding Sauer A.
        • et al.
        Colorectal cancer statistics, 2020.
        CA Cancer J Clin. 2020; 70: 145-164https://doi.org/10.3322/caac.21601
        • Kornblith A.B.
        • Huang H.Q.
        • Walker J.L.
        • Spirtos N.M.
        • Rotmensch J.
        • Cella D.
        Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study [published correction appears in.
        J Clin Oncol. 2009; 27 (J Clin Oncol. 2010 Jun 1;28(16):2805]): 5337-5342https://doi.org/10.1200/JCO.2009.22.3529
      1. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer.
        Obstet Gynecol. 2005; 106: 413-425
        • Watari H.
        • Katayama H.
        • Shibata T.
        • et al.
        Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).
        Jpn J Clin Oncol. 2017 Oct 1; 47: 986-990https://doi.org/10.1093/jjco/hyx108
        • Colombo N.
        • Creutzberg C.
        • Amant F.
        • et al.
        ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up.
        Radiother Oncol. 2015; 117: 559-581https://doi.org/10.1016/j.radonc.2015.11.013
        • Benedetti Panici P.
        • Basile S.
        • Maneschi F.
        • et al.
        Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
        J Natl Cancer Inst. 2008; 100: 1707-1716https://doi.org/10.1093/jnci/djn397
        • Kitchener H.
        • Swart A.M.
        • Qian Q.
        • Amos C.
        • Parmar M.K.
        • ASTEC study group
        Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study [published correction appears in Lancet.
        Lancet. 2009; 373 (2009 May 23;373(9677):1764]): 125-136https://doi.org/10.1016/S0140-6736(08)61766-3
        • Raspagliesi F.
        • Ditto A.
        • Kusamura S.
        • et al.
        Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study.
        Am J Obstet Gynecol. 2004 Aug; 191: 435-439
        • Ditto A.
        • Martinelli F.
        • Bogani G.
        • Papadia A.
        • Lorusso D.
        • Raspagliesi F.
        Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging.
        J Minim Invasive Gynecol. 2015 Jan; 22 (Epub 2014 Aug 15): 132-133https://doi.org/10.1016/j.jmig.2014.08.009
        • Bogani G.
        • Raspagliesi F.
        Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?.
        J Gynecol Oncol. 2019; 30: e68https://doi.org/10.3802/jgo.2019.30.e68
        • Ballester M.
        • Dubernard G.
        • Lécuru F.
        • et al.
        Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
        Lancet Oncol. 2011; 12: 469-476https://doi.org/10.1016/S1470-2045(11)70070-5
        • Zahl Eriksson A.G.
        • Ducie J.
        • Ali N.
        • et al.
        Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
        Gynecol Oncol. 2016; 140: 394-399https://doi.org/10.1016/j.ygyno.2015.12.028
        • Ducie J.A.
        • Eriksson A.G.Z.
        • Ali N.
        • et al.
        Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
        Gynecol Oncol. 2017; 147: 541-548https://doi.org/10.1016/j.ygyno.2017.09.030
        • Nccn
        NCCN clinical practice guidelines in oncology, uterine neoplasms. version 1.2020.
        2020 (Available:)
        • Obermair A.
        • Abu-Rustum N.R.
        Sentinel lymph node mapping in endometrial cancer - areas where further research is needed.
        Int J Gynecol Canc. 2020 Jan 17; (pii: ijgc-2019-001089)https://doi.org/10.1136/ijgc-2019-001089
        • Bollino M.
        • Geppert B.
        • Lönnerfors C.
        • Falconer H.
        • Salehi S.
        • Persson J.
        Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
        Int J Gynecol Canc. 2020; 30: 339-345https://doi.org/10.1136/ijgc-2019-000935
        • Martinelli F.
        • Ditto A.
        • Signorelli M.
        • et al.
        Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: a single center evaluation over 200 cases.
        Gynecol Oncol. 2017 Sep; 146 (Epub 2017 Jul 5): 525-530https://doi.org/10.1016/j.ygyno.2017.06.014
        • Bogani G.
        • Murgia F.
        • Ditto A.
        • Raspagliesi F.
        Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis.
        Gynecol Oncol. 2019; 153: 676-683https://doi.org/10.1016/j.ygyno.2019.03.254
        • Rossi E.C.
        • Kowalski L.D.
        • Scalici J.
        • et al.
        A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
        Lancet Oncol. 2017; 18: 384-392https://doi.org/10.1016/S1470-2045(17)30068-2
        • Solima E.
        • Martinelli F.
        • Ditto A.
        • et al.
        Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer.
        Gynecol Oncol. 2012; 126: 419-423
        • Maccauro M.
        • Lucignani G.
        • Aliberti G.
        • et al.
        Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.
        Eur J Nucl Med Mol Imag. 2005; 32: 569-574
        • Mariani A.
        • Keeney G.L.
        • Aletti G.
        • Webb M.J.
        • Haddock M.G.
        Podratz KC Endometrial carcinoma: paraaortic dissemination.
        Gynecol Oncol. 2004 Mar; 92: 833-838
        • Cormier B.
        • Rozenholc A.T.
        • Gotlieb W.
        • Plante M.
        • Giede C.
        Communities of Practice (CoP) Group of Society of Gynecologic Oncology of Canada (GOC). Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research.
        Gynecol Oncol. 2015; 138: 478-485https://doi.org/10.1016/j.ygyno.2015.05.039
        • Frumovitz M.
        • Plante M.
        • Lee P.S.
        • et al.
        Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
        Lancet Oncol. 2018; 19: 1394-1403https://doi.org/10.1016/S1470-2045(18)30448-0
        • Clavien P.A.
        • Barkun J.
        • de Oliveira M.L.
        • et al.
        The Clavien-Dindo classification of surgical complications: five-year experience.
        Ann Surg. 2009; 250: 187-196https://doi.org/10.1097/SLA.0b013e3181b13ca2
        • Gezer Ş.
        • Duman Öztürk S.
        • Hekimsoy T.
        • et al.
        Cervical versus endometrial injection for sentinel lymph node detection in endometrial cancer: a randomized clinical trial.
        Int J Gynecol Canc. 2020; 30: 325-331https://doi.org/10.1136/ijgc-2019-000860
        • Rossi E.C.
        • Jackson A.
        • Ivanova A.
        • Boggess J.F.
        Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection.
        Int J Gynecol Canc. 2013; 23: 1704-1711https://doi.org/10.1097/IGC.0b013e3182a616f6
        • Persson J.
        • Salehi S.
        • Bollino M.
        • Lönnerfors C.
        • Falconer H.
        • Geppert B.
        Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging.
        Eur J Canc. 2019; 116: 77-85
        • Persson J.
        • Geppert B.
        • Lönnerfors C.
        • Bollino M.
        • Måsbäck A.
        Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer.
        Gynecol Oncol. 2017; 147: 120-125https://doi.org/10.1016/j.ygyno.2017.07.131
        • Bogani G.
        • Casarin J.
        • Maggiore U.L.R.
        • et al.
        Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: long-term results of a propensity-matched analysis.
        Gynecol Oncol. 2020; 158: 77-83https://doi.org/10.1016/j.ygyno.2020.04.691
        • Bogani G.
        • Multinu F.
        • Dowdy S.C.
        • et al.
        Incorporating robotic-assisted surgery for endometrial cancer staging: analysis of morbidity and costs.
        Gynecol Oncol. 2016; 141: 218-224https://doi.org/10.1016/j.ygyno.2016.02.016
        • Ghezzi F.
        • Uccella S.
        • Cromi A.
        • et al.
        Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging.
        Ann Surg Oncol. 2012; 19: 259-267https://doi.org/10.1245/s10434-011-1854-5

      Linked Article